Publication & Citation Trends
Publications
0 total
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing OA
Cited by 56
Semantic Scholar
Selecting the right therapeutic target for kidney disease OA
Cited by 10
Semantic Scholar
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes OA
Cited by 25
Semantic Scholar
A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation OA
Cited by 9
Semantic Scholar
Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling OA
Cited by 7
Semantic Scholar
TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis OA
Cited by 16
Semantic Scholar
Sphingosine 1-phosphate mediates adiponectin receptor signaling essential for lipid homeostasis and embryogenesis OA
Cited by 26
Semantic Scholar
Rare variant contribution to human disease in 281,104 UK Biobank exomes OA
Cited by 456
Semantic Scholar
Research Topics
Adipose Tissue and Metabolism
(25)
Growth Hormone and Insulin-like Growth Factors
(22)
CRISPR and Genetic Engineering
(22)
Regulation of Appetite and Obesity
(19)
Adipokines, Inflammation, and Metabolic Diseases
(13)
Affiliations
AstraZeneca (United Kingdom)
Sahlgrenska University Hospital
Ospedale Cisanello
Brain Physiology Lab
AstraZeneca (Brazil)